Company Directory / research

PrivateFor profitresearchSeattle, United States
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
Size
51-100 people: larger than 75% of companies with a size listed
Age
6 years old.
Reach
Website ranked #5,142,302 in the world for traffic, about 2k visits a month.
BiotechnologyHealth CareLife SciencePharmaceutical
Funding, as listed
$199M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Outpace Bio, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Outpace Bio may be growing as it has secured a 3,500 square foot lease at Dexter Yard and has plans for a 12,000 square foot expansion. This expansion of their physical footprint suggests an increase in operational capacity. The commitment to a larger space often correlates with a growing team and the need for more resources to support increased business activities.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.